<DOC>
	<DOCNO>NCT02723968</DOCNO>
	<brief_summary>Cystic fibrosis-related diabetes late cystic fibrosis ( CF ) associate comorbidity whose prevalence increase sharply lifelong . Guidelines glucose metabolism ( GM ) monitoring rely oral glucose tolerance test . However , test neither sensitive specific . The aim study compare sensitivity specificity different method GM monitor child adolescent CF . Continuous GM system ( CGMS ) use reference method . Results compare oral glucose tolerance test ( OGTT ) , intravenous glucose tolerance test ( IGTT ) , homeostasis model assessment index insulin resistance ( HOMA- % IR ) , homeostasis model assessment index beta-cell function ( HOMA- % B ) HbA1C dosage ( glycated haemoglobin A1C ) . Patients classify three group accord CGMS : normal glucose tolerance , impair glucose tolerance diabetes mellitus .</brief_summary>
	<brief_title>Cystic Fibrosis Related Diabetes Screening .</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Subjects confirm diagnosis Cystic Fibrosis sweat chloride &gt; 60 mmol/L . Subjects age 10 18 year least one class 1 2 Cystic fibrosis transmembrane conductance regulator ( CFTR ) mutation . Subjects pancreatic insufficient . Subjects must force expiratory volume 1 ( FEV1 ) &gt; 40 % predict normal age , sex height screen visit . Stable CF disease judge investigator Subjects glucose intolerance abnormality Subjects pulmonary exacerbation within 4 week screen History lung hepatic transplantation await transplantation</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>